Literature DB >> 8532067

Stimulation of serotonin release in the rat brain cortex by activation of ionotropic glutamate receptors and its modulation via alpha 2-heteroreceptors.

K Fink1, V Schmitz, C Böing, M Göthert.   

Abstract

Rat brain cortex slices were used to study (1) the release of 5-hydroxytryptamine (5-HT) induced by activation of N-methyl-D-aspartate (NMDA) or non-NMDA receptors and (2) the alpha 2-adrenoceptor-mediated modulation of NMDA-evoked 5-HT release. Cortical slices were preincubated with [3H]5-HT in the presence of the selective noradrenaline uptake inhibitor, maprotiline (to avoid false labelling of noradrenergic axon terminals), and the superfused with solution containing the 5-HT reuptake inhibitor, 6-nitroquipazine. In slices superfused with Mg(2+)-free medium, NMDA and L-glutamate, in a concentration-dependent manner, elicited an overflow of tritium. The NMDA-evoked tritium overflow was abolished by omission of Ca2+ ions, almost completely suppressed by 1.2 mM Mg2+ and only partly (by about 60%) inhibited by tetrodotoxin. Dizocilpine (formerly MK-801), an antagonist at the phencyclidine site within the NMDA-gated channel, also decreased the NMDA-evoked overflow. The competitive NMDA receptor antagonist DL-(E)-2-amino-4-methyl-5-phosphono-3-pentanoic acid (CGP 37849) caused a parallel shift of the NMDA concentration-response curve to the right. The NMDA-induced tritium overflow was not affected by addition of exogenous glycine but was inhibited by 5,7-dichlorokynurenic acid, an antagonist at the glycine site of the NMDA receptor. Spermidine slightly increased the NMDA-induced tritium overflow whereas arcaine, an antagonist at the polyamine site of the NMDA-receptor, caused a decrease. Ifenprodil and eliprodil, which exhibit different affinities for NMDA receptors composed of different subunits were highly potent (in the nanomolar range) in inhibiting the NMDA-evoked tritium overflow. Noradrenaline reduced, whereas the alpha 2-adrenoceptor antagonist idazoxan facilitated, the NMDA-evoked overflow. Idazoxan shifted the concentration-response curve of noradrenaline to the right. In slices superfused with solution containing 1.2 mM Mg2+, kainic acid or (RS)-alpha-amino-3-hydroxy-5-methyl-4 -isoxazole propionic acid (AMPA) also caused a concentration-dependent overflow of tritium, which again was not completely (by about 75 and 50%, respectively) inhibited by tetrodotoxin. The kainate-evoked tritium overflow was inhibited by the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) but not affected by CGP 37849 or arcaine. The AMPA-evoked tritium overflow was also decreased by CNQX. It is concluded that activation of NMDA or non-NMDA receptors elicits a release of 5-HT in the rat brain cortex. The receptors are at least partly located on the serotoninergic nerve terminals. The results with ifenprodil and eliprodil are compatible with the view that the NMDA receptor involved contains the NR2B subunit. The NMDA-evoked 5-HT release is modulated by presynaptic alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532067     DOI: 10.1007/bf00172776

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

Review 1.  The TiPS/TINS lecture: the molecular biology of mammalian glutamate receptor channels.

Authors:  P H Seeburg
Journal:  Trends Pharmacol Sci       Date:  1993-08       Impact factor: 14.819

2.  Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex.

Authors:  K Fink; H Bönisch; M Göthert
Journal:  Eur J Pharmacol       Date:  1990-08-21       Impact factor: 4.432

3.  [3H]CPP, a new competitive ligand for NMDA receptors.

Authors:  H J Olverman; D T Monaghan; C W Cotman; J C Watkins
Journal:  Eur J Pharmacol       Date:  1986-11-12       Impact factor: 4.432

4.  Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus.

Authors:  A Pittaluga; M Raiteri
Journal:  Eur J Pharmacol       Date:  1990-11-27       Impact factor: 4.432

5.  Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices.

Authors:  J Lehmann; B Scatton
Journal:  Brain Res       Date:  1982-12-02       Impact factor: 3.252

6.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.

Authors:  M L Mayer; G L Westbrook; P B Guthrie
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

7.  Pharmacological characterization of presynaptic alpha-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat.

Authors:  A L Frankhuyzen; A H Mulder
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

Review 8.  Properties of vertebrate glutamate receptors: calcium mobilization and desensitization.

Authors:  C F Zorumski; L L Thio
Journal:  Prog Neurobiol       Date:  1992-09       Impact factor: 11.685

9.  CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.

Authors:  G E Fagg; H R Olpe; M F Pozza; J Baud; M Steinmann; M Schmutz; C Portet; P Baumann; K Thedinga; H Bittiger
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

10.  Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.

Authors:  S M Jones; L D Snell; K M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

View more
  5 in total

1.  Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release.

Authors:  Anna Pittaluga; Daniela Segantini; Marco Feligioni; Maurizio Raiteri
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

2.  Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition.

Authors:  K Fink; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Authors:  J Srinivasan; Werner J Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-29       Impact factor: 3.000

Review 4.  Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders.

Authors:  Yi Liu; Jingping Zhao; Xiaoduo Fan; Wenbin Guo
Journal:  Front Psychiatry       Date:  2019-05-21       Impact factor: 4.157

Review 5.  Presynaptic release-regulating NMDA receptors in isolated nerve terminals: A narrative review.

Authors:  Anna Pittaluga
Journal:  Br J Pharmacol       Date:  2021-02-02       Impact factor: 9.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.